In humans as well as in animals, beta-2 adrenoreceptor agonists intravenously injected or aerosolized and administered through the airway were reported to have protective effects against a variety of pulmonary conditions, such as acute respiratory distress syndrome and pulmonary edema after lung resection [57,72,90]. The gene discussed is ADRB2; the disease is acute respiratory distress syndrome.